Krishnan Suma bought KRYS

February 27, 2026 · Form 4 insider transaction

Krishnan Suma bought 43,536 shares of Krystal Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
43,536
Price
$0.00
Total value
N/A
Role
SecurityPerformance Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after43,536
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each PSU represents a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the three year performance period, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on the vesting date.; The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the performance criteria set by the Company's Compensation Committee for this PSU award and full vesting of this PSU award.; If any applicable portion of the performance criteria have been achieved, the PSU award shall cliff vest on February 27, 2029.; If some or all of the performance criteria are not achieved, the applicable portion of the PSU award will be forfeited.

View the original Form 4 on SEC EDGAR